Scopolamine Transdermal Patches and Dizziness
Yes, scopolamine transdermal patches do cause dizziness as a common side effect. Dizziness is explicitly listed among the most frequent adverse reactions associated with this medication.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information clearly identifies dizziness as one of the most common side effects of scopolamine transdermal system 1:
- Dizziness occurs in approximately 12% of patients receiving scopolamine patches compared to 7% with placebo in postoperative nausea and vomiting (PONV) clinical trials 1
- The FDA label explicitly lists dizziness among "the most common side effects" alongside dry mouth, blurred vision, drowsiness, and disorientation 1
Clinical Practice Guideline Perspectives
Multiple clinical guidelines acknowledge the dizziness risk with scopolamine:
- The American Academy of Otolaryngology-Head and Neck Surgery (2020) guidelines for Ménière's disease note that scopolamine and other anticholinergics "can cause blurring of vision, dry mouth, dilated pupils, urinary retention, and sedation" 2
- The American Heart Association/American Stroke Association (2023) guidelines caution that anticholinergics like scopolamine "may impair neurological examination" due to confusion or sedation 3
Withdrawal-Related Dizziness
A critical caveat: dizziness can also occur as a withdrawal symptom after removing scopolamine patches, particularly after prolonged use:
- Withdrawal symptoms including "difficulty with balance, dizziness, nausea, vomiting, stomach cramps, sweating, confusion, muscle weakness, low heart rate or low blood pressure" can start 24 hours or more after patch removal 1
- A case report documented severe disabling dizziness developing 24-36 hours after patch removal in a patient who had worn the patch continuously for 7 days 4
Clinical Implications
Patients should be counseled about both types of dizziness risk:
During use: Dizziness while wearing the patch affects approximately 12% of patients and warrants caution with driving, operating machinery, or participating in water sports 1
After removal: Withdrawal-related dizziness can be severe and disabling, particularly after continuous use for several days, and may require medical attention if symptoms become severe 1, 4
The transdermal route appears to have a more favorable side effect profile compared to injectable routes, though dizziness remains a documented adverse effect across all administration methods 5.